Cargando…
Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells
Short chain fatty acids (SCFAs), especially butyrate (BUT), are known to promote intestinal health, but their role in the protection of intestinal barrier integrity is poorly characterized. The aim of the study was to set up an in vitro model of human colon epithelium using HT29-MTX-E12 cells to del...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265952/ https://www.ncbi.nlm.nih.gov/pubmed/35804798 http://dx.doi.org/10.3390/foods11131983 |
_version_ | 1784743342662221824 |
---|---|
author | Giromini, Carlotta Baldi, Antonella Rebucci, Raffaella Lanzoni, Davide Policardi, Martina Sundaram, Tamil selvi Purup, Stig |
author_facet | Giromini, Carlotta Baldi, Antonella Rebucci, Raffaella Lanzoni, Davide Policardi, Martina Sundaram, Tamil selvi Purup, Stig |
author_sort | Giromini, Carlotta |
collection | PubMed |
description | Short chain fatty acids (SCFAs), especially butyrate (BUT), are known to promote intestinal health, but their role in the protection of intestinal barrier integrity is poorly characterized. The aim of the study was to set up an in vitro model of human colon epithelium using HT29-MTX-E12 cells to delineate the potential role of SCFAs under stress conditions. Accordingly, the HT29-MTX-E12 cells were differentiated for 42 days and subsequently exposed to dextran sulphate sodium (DSS). Further, the effects of BUT or its mixture with acetate and propionate (SCFAs-MIX) were tested to study proliferation, epithelial integrity and mucus production. The results showed that the concentration of 10% DSS for 24 h decreased the TEER about 50% compared to the control in HT29-MTX-E12 cells. The pre-treatment on HT29-MTX-E12 cells with BUT or SCFAs-MIX at specific concentrations significantly (p < 0.05) reduced the DSS-induced damage on epithelial cell integrity and permeability. Further, the treatment with specific concentrations of BUT and SCFAs-MIX for 24 h significantly promoted ZO-1, MUC2 and MUC5AC mRNA expression (p < 0.005). The present study demonstrated the suitability of HT29-MTX-E12 cells treated with DSS as an in vitro stress model of inflammatory bowel disease, which enabled us to understand the effect of bioactive SCFAs on the intestinal barrier. |
format | Online Article Text |
id | pubmed-9265952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92659522022-07-09 Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells Giromini, Carlotta Baldi, Antonella Rebucci, Raffaella Lanzoni, Davide Policardi, Martina Sundaram, Tamil selvi Purup, Stig Foods Article Short chain fatty acids (SCFAs), especially butyrate (BUT), are known to promote intestinal health, but their role in the protection of intestinal barrier integrity is poorly characterized. The aim of the study was to set up an in vitro model of human colon epithelium using HT29-MTX-E12 cells to delineate the potential role of SCFAs under stress conditions. Accordingly, the HT29-MTX-E12 cells were differentiated for 42 days and subsequently exposed to dextran sulphate sodium (DSS). Further, the effects of BUT or its mixture with acetate and propionate (SCFAs-MIX) were tested to study proliferation, epithelial integrity and mucus production. The results showed that the concentration of 10% DSS for 24 h decreased the TEER about 50% compared to the control in HT29-MTX-E12 cells. The pre-treatment on HT29-MTX-E12 cells with BUT or SCFAs-MIX at specific concentrations significantly (p < 0.05) reduced the DSS-induced damage on epithelial cell integrity and permeability. Further, the treatment with specific concentrations of BUT and SCFAs-MIX for 24 h significantly promoted ZO-1, MUC2 and MUC5AC mRNA expression (p < 0.005). The present study demonstrated the suitability of HT29-MTX-E12 cells treated with DSS as an in vitro stress model of inflammatory bowel disease, which enabled us to understand the effect of bioactive SCFAs on the intestinal barrier. MDPI 2022-07-05 /pmc/articles/PMC9265952/ /pubmed/35804798 http://dx.doi.org/10.3390/foods11131983 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Giromini, Carlotta Baldi, Antonella Rebucci, Raffaella Lanzoni, Davide Policardi, Martina Sundaram, Tamil selvi Purup, Stig Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells |
title | Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells |
title_full | Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells |
title_fullStr | Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells |
title_full_unstemmed | Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells |
title_short | Role of Short Chain Fatty Acids to Counteract Inflammatory Stress and Mucus Production in Human Intestinal HT29-MTX-E12 Cells |
title_sort | role of short chain fatty acids to counteract inflammatory stress and mucus production in human intestinal ht29-mtx-e12 cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265952/ https://www.ncbi.nlm.nih.gov/pubmed/35804798 http://dx.doi.org/10.3390/foods11131983 |
work_keys_str_mv | AT girominicarlotta roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells AT baldiantonella roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells AT rebucciraffaella roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells AT lanzonidavide roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells AT policardimartina roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells AT sundaramtamilselvi roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells AT purupstig roleofshortchainfattyacidstocounteractinflammatorystressandmucusproductioninhumanintestinalht29mtxe12cells |